For the Inventor, By the Inventor

Enter assignee name

Huntsville, AL, United States of America

Serina Therapeutics, Inc.

USPTO Granted Patents = 23

CIPO Patents = 4

EPO Patents = 4

Trademarks = 5

Forward Citations = 99

Loading Chart...

Loading Chart...

21 inventors (with patents filed for the assignee):

Michael David Bentley (23 out of 136 patents)

Kunsang Yoon (20 out of 24 patents)

Zhihao Fang (19 out of 45 patents)

4. Tacey Viegas (17 out of 39 patents)

5. J Milton Harris (14 out of 89 patents)

6. Randall Moreadith (10 out of 11 patents)

7. Rebecca Weimer (8 out of 12 patents)

8. Bekir Dizman (6 out of 7 patents)

9. Francesco Maria Veronese (3 out of 17 patents)

10. Michael Reif (2 out of 2 patents)

11. Anna Mero (1 out of 1 patent)

12. Rainer Jordan (1 out of 1 patent)

13. Rainer Jordon (1 out of 1 patent)

14. Robert J Sharpe (1 out of 1 patent)

15. Ribecca Weimer (0 patent)

23 patents: Sort by Forward Citations

1. 12233132 - Polyoxazoline-lipid conjugates and lipid nanoparticles and pharmaceutical compositions including same (2025-02-25),

2. 11944618 - Subcutaneous delivery of polymer conjugates of therapeutic agents (2024-04-02),

3. 11925689 - Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same (2024-03-12),

4. 11766432 - Cleavable conjugates of catechol compounds and water-soluble polymers and methods of treatment using the same (2023-09-26),

5. 11298350 - Subcutaneous delivery of polymer conjugates of therapeutics agents (2022-04-12),

6. 11224595 - Subcutaneous delivery of poly(oxazoline) polymer conjugates (2022-01-18),

7. 11213588 - Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same (2022-01-04),

8. 11065340 - Polyoxazoline antibody drug conjugates (2021-07-20),

9. 10864276 - Activated polyoxazolines and conjugates and compositions comprising the same (2020-12-15),

10. 10314837 - Subcutaneous delivery of poly(oxazoline) polymer conjugates (2019-06-11),

11. 10166294 - Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same (2019-01-01),

12. 10086084 - Activated polyoxazolines and conjugates and compositions comprising the same (2018-10-02),

13. 10071168 - Polyoxazoline antibody drug conjugates (2018-09-11),

14. 9284411 - Polyoxazolines with inert terminating groups, polyoxazolines prepared from protected initiating groups and related compounds (2016-03-15),

15. 9169354 - Multifunctional forms of polyoxazoline copolymers and drug compositions comprising the same (2015-10-27),

Serina Therapeutics, Inc. is a biotechnology company focused on developing novel therapeutics using its proprietary polymer technology. With a mission to improve the lives of patients, Serina Therapeutics is advancing a robust pipeline of drugs for a range of medical conditions. The company's unique platform enables the controlled release of active pharmaceutical ingredients, enhancing drug delivery and efficacy. Serina Therapeutics' innovative research and development efforts have earned recognition in the biotech industry, positioning the company as a leader in drug delivery technology.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

23 Patents

#18 in Huntsville, AL

#56 in Alabama

#13,925 in US

#26,790 in the World

Huntsville, AL, United States of America

Serina Therapeutics, Inc.

Forward Citations = 99

21 inventors:

Michael David Bentley (23 out of 136 patents)

Kunsang Yoon (20 out of 24 patents)

Zhihao Fang (19 out of 45 patents)

4. Tacey Viegas (17 out of 39 patents)

5. J Milton Harris (14 out of 89 patents)

Please report any incorrect information to support@idiyas.com

Loading…